FDA NDC Directory · JSON-LD · Markdown

Deferasirox

NDC 69539-075 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerMSN LABORATORIES PRIVATE LIMITED
Marketing categoryAbbreviated NDA (generic) · App ANDA210945
Dosage form / routeTABLET · ORAL
Active ingredientsDEFERASIROX (360 mg/1)
Marketing started20191120
Package count2

External sources

Source: openFDA. Public-domain (CC0).